Development of Hypoxia Selective Cytotoxins for Cancer Treatment: An Update

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|2|3|315-327

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.2, Iss.3, 2006-01, pp. : 315-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Oxides as Hypoxia Selective Cytotoxins

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 3, 2001-09 ,pp. : 219-231

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer

By Safe S.   Qin C.   McDougal A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1385-1396

Informa Healthcare

Access to resources Recommend Favorite

The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 11, Iss. 14, 2005-05 ,pp. : 1771-1777

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic aspects in treatment of colorectal cancer – an update

By Stoehlmacher Jan   Goekkurt Eray   Lenz Heinz-Josef  

Pharmacogenomics, Vol. 4, Iss. 6, 2003-11 ,pp. : 767-777

Future Medicine

Access to resources Recommend Favorite